TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
TCL Archive Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says December 5, 1997
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010